Markets
Research
My lists
/
Market
/
Healthcare
/
Drug Manufacturers - Specialty & Generic
Drug Manufacturers - Specialty & Generic
(industry)
Compare top 5 →
Overview
Performance
Composition
Scores
Scores & Valuation
Companies
Companies
Q-Score
54
Market Cap
C$23.9B
Aggregate P/E
—
Dividend Yield
5.18%
1Y Return
+30.0%
Advancing (1M)
50.00%
Returns
+30.0%
over the year
Cap-weighted
Median
Up
1M
+17.6%
+0.6%
50%
3M
+9.6%
-2.3%
45%
YTD
+29.2%
+6.2%
55%
1Y
+30.0%
+14.4%
62%
Led by the largest companies: the median company returned +14.4%.
Returns by horizon and breadth
→
This month's movers
Leaders
BHC.TO
Bausch Health Companies Inc.
+42.5%
APTX.TO
Apotex Health Corp.
+27.7%
Laggards
TLRY.TO
Tilray Brands, Inc.
-25.0%
CURA.TO
Curaleaf Holdings, Inc.
-10.6%
Every horizon's leaders and laggards
→
Largest companies
APTX.TO
37.8%
BHC.TO
18.6%
CURA.TO
12.4%
CRON.TO
7.4%
GUD.TO
5.0%
DHT-UN.TO
4.5%
TLRY.TO
2.2%
ACB.TO
1.9%
The map and every share
→
Size
Revenue
C$25B
Earnings
C$-1.7B
Companies
22
Concentration (HHI)
0.24
Size and financials
→
Q-Score profile
54
/ 100
Every score and metric
→
Valuation
Aggregate P/E
—
Aggregate P/S
0.96
Dividend yield
5.18%
Earnings yield
—
Net margin
-6.82%
The valuation map
→